Association between systemic treatment with immune checkpoint inhibitor therapy in renal cell carcinoma and reduced risk of brain metastasis development.

Damante, Mark; Huntoon, Kristin; Gibbs, David; Pezzutti, Dante; Olencki, Thomas; Elder, J Bradley

Damante, Mark; Huntoon, Kristin; Gibbs, David; Pezzutti, Dante; Olencki, Thomas; Elder, J Bradley.

Afiliación

Damante M; 1Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Huntoon K; 1Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Gibbs D; 2The Ohio State University College of Medicine, Columbus, Ohio; and.
Pezzutti D; 2The Ohio State University College of Medicine, Columbus, Ohio; and.
Olencki T; 3Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Elder JB; 1Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.

Neurosurg Focus ; 55(2): E2, 2023 08.

Article en En | MEDLINE | ID: mdl-37527670

Asunto(s)

Neoplasias Encefálicas; Carcinoma de Células Renales; Neoplasias Renales; Humanos; Carcinoma de Células Renales/tratamiento farmacológico; Neoplasias Renales/tratamiento farmacológico; Inhibidores de Puntos de Control Inmunológico/uso terapéutico; Estudios Retrospectivos; Estudios Prospectivos; Neoplasias Encefálicas/patología

Palabras clave

brain metastasis; checkpoint inhibitor; molecular targeted therapy; renal cell carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Neurosurg Focus Asunto de la revista: NEUROCIRURGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google